Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS

Kaori Kadoyama, Akiko Kuwahara, Motohiro Yamamori, +3

Journal of Experimental & Clinical Cancer Research

Association of VEGF genotype with mRNA level in colorectal adenocarcinomas

Motohiro Yamamori, Toshiyuki Sakaeda, Tsutomu Nakamura, +11

Biochemical and Biophysical Research Communications

MedicineColorectal CancerPathologyCancer GenomicsCancer Genetics +6

Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma

Noboru Okamura, Taro Masuda, Akinobu Gotoh, +16

PROTEOMICS

Nbs ReagentPathologyQuantitative Proteomic AnalysisTumor BiologyProteomic Technology +16

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, +9

International Journal of Medical Sciences

Favorable Genetic Polymorphisms Predictive of Clinical Outcome of Chemoradiotherapy for Stage II/III Esophageal Squamous Cell Carcinoma in Japanese

Tatsuya Okuno, Takao Tamura, Motohiro Yamamori, +12

American Journal of Clinical Oncology

Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer

Kyoko Seki, Kenzou Senzaki, Yasuo Tsuduki, +12

International Journal of Medical Sciences

Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma

M. Fujita, Tatsurou Yagami, Miki Fujio, +5

Cancer Letters

Tumor BiologyUrologyPparγ-independent PathwayGenitourinary CancerMedicine +7

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer

Megumi Fujita, Ai Hasegawa, Motohiro Yamamori, +1

Journal of Experimental & Clinical Cancer Research

Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma

Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, +10

International Journal of Medical Sciences

Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation

Atsuo Okamura, Motohiro Yamamori, Manabu Shimoyama, +10

International Journal of Hematology

Pharmacokinetics-based Optimal Dose-explorationMycophenolate MofetilTransplantationMedicineStem Cell Mobilization +5